Pharmacodynamic and pharmacokinetic effects of brivaracetam in healthy women taking oral contraceptives.

Trial Profile

Pharmacodynamic and pharmacokinetic effects of brivaracetam in healthy women taking oral contraceptives.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Apr 2014

At a glance

  • Drugs Brivaracetam (Primary) ; Ethinylestradiol/levonorgestrel (Primary)
  • Indications Epilepsy; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors UCB Pharma AG
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top